Last Updated: June 25, 2026

Suppliers and packagers for EVISTA

✉ Email this page to a colleague

EVISTA

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Lilly	EVISTA	raloxifene hydrochloride	TABLET;ORAL	020815	NDA	Eli Lilly and Company	0002-4184-30	30 TABLET in 1 BOTTLE (0002-4184-30)	1998-01-06
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Suppliers and packagers for EVISTA

Last updated: June 2, 2026

EVISTA (raloxifene) suppliers: which manufacturers make the API, tablets, and key contract partners

Executive summary: EVISTA is a branded raloxifene product marketed in the US by Eli Lilly and Company. Raloxifene is supplied through a mature, generic-enabled manufacturing chain that typically includes (1) API producers of raloxifene hydrochloride and (2) contract manufacturers that compress and package raloxifene tablets under quality systems aligned to FDA and global cGMP.

Actionable bottleneck for due diligence: to identify the current EVISTA label-stage suppliers (API site(s) and finished-dose CMO/packager), you must cross-check FDA Orange Book drug listings (listed manufacturers and dosage-form manufacturers), DMF holders for raloxifene intermediates/API referenced by the approved NDA, and inspection histories tied to those sites.

However, no authoritative supplier list can be produced from the information provided.

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.